196 related articles for article (PubMed ID: 21882119)
1. Preventive medicines: vaccination, prophylaxis of infectious diseases, disinfectants.
Heininger U
Handb Exp Pharmacol; 2011; 205():317-37. PubMed ID: 21882119
[TBL] [Abstract][Full Text] [Related]
2. Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.
Ball R; Horne D; Izurieta H; Sutherland A; Walderhaug M; Hsu H
Pediatrics; 2011 May; 127 Suppl 1():S31-8. PubMed ID: 21502249
[TBL] [Abstract][Full Text] [Related]
3. Monitoring and assessing vaccine safety: a European perspective.
Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
[TBL] [Abstract][Full Text] [Related]
4. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.
Bonhoeffer J; Black S; Izurieta H; Zuber P; Sturkenboom M
Biologicals; 2012 Sep; 40(5):393-7. PubMed ID: 22902972
[TBL] [Abstract][Full Text] [Related]
5. Vaccines in the pipeline: the path from development to use in the United States.
Pickering LK; Walton LR
Pediatr Ann; 2013 Aug; 42(8):146-52. PubMed ID: 23910027
[TBL] [Abstract][Full Text] [Related]
6. Assuring the quality, safety, and efficacy of DNA vaccines.
Robertson JS; Griffiths E
Methods Mol Med; 2006; 127():363-74. PubMed ID: 16988466
[TBL] [Abstract][Full Text] [Related]
7. [From molecule to medicine--drug development].
Bruhn C
Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355
[No Abstract] [Full Text] [Related]
8. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
[TBL] [Abstract][Full Text] [Related]
9. Food and Drug Administration regulation and evaluation of vaccines.
Marshall V; Baylor NW
Pediatrics; 2011 May; 127 Suppl 1():S23-30. PubMed ID: 21502242
[TBL] [Abstract][Full Text] [Related]
10. [From the licensure of vaccines to the recommendation of the Standing Committee on Vaccination in Germany : criteria for the assessment of benefits and risks].
Pfleiderer M; Wichmann O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Mar; 58(3):263-73. PubMed ID: 25566841
[TBL] [Abstract][Full Text] [Related]
11. Immunizations in the United States: success, structure, and stress.
Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
[TBL] [Abstract][Full Text] [Related]
12. [Dengue fever: from disease to vaccination].
Teyssou R
Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
[TBL] [Abstract][Full Text] [Related]
13. Vaccines under study: non-HIV vaccines.
Conner K; Wuu A; Maldonado V; Bartlett BL; Tyring SK
Dermatol Ther; 2009; 22(2):168-85. PubMed ID: 19335728
[TBL] [Abstract][Full Text] [Related]
14. [Learning from the US immunization administration].
Kamiya H; Kamiya H
Nihon Rinsho; 2008 Oct; 66(10):1858-64. PubMed ID: 18939482
[TBL] [Abstract][Full Text] [Related]
15. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
André FE; Foulkes MA
Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
[TBL] [Abstract][Full Text] [Related]
16. Field evaluation of vaccine safety.
Tozzi AE
Vaccine; 2004 May; 22(15-16):2091-5. PubMed ID: 15121330
[TBL] [Abstract][Full Text] [Related]
17. US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007.
Gruber MF
Expert Rev Vaccines; 2011 Jul; 10(7):1011-9. PubMed ID: 21806396
[TBL] [Abstract][Full Text] [Related]
18. Development and approval of vaccines in the United States.
Botstein P
Isr J Med Sci; 1986; 22(3-4):268-71. PubMed ID: 3528047
[TBL] [Abstract][Full Text] [Related]
19. Pediatric immunization update 2002.
Paulson PR; Hammer AL
Pediatr Nurs; 2002; 28(2):173-81. PubMed ID: 11962186
[TBL] [Abstract][Full Text] [Related]
20. Human clinical trials of plasmid DNA vaccines.
Liu MA; Ulmer JB
Adv Genet; 2005; 55():25-40. PubMed ID: 16291211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
